This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Personal history of malignant neoplasm
Z21_PERSONAL_HISTORY_MALIG_NEOPLASM
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
1375 |
4. Check minimum number of eventsNone |
1375 |
5. Include endpointsNone |
1375 |
6. Filter based on genotype QC (FinnGen only) |
1375 |
Control definitions (FinnGen only)
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- Z[8-9]
Similar endpoints
↥List of similar endpoints to
Personal history of malignant neoplasm
based on the number of shared cases.
Similar with more cases:
- Persons with potential health hazards related to family and personal history and certain conditions influencing health status
- Factors influencing health status and contact with health services
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1375 | 1129 | 246 |
| Unadjusted period prevalence (%) | 0.34 | 0.38 | 0.11 |
| Median age at first event (years) | 61.65 | 61.62 | 61.77 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1135
- Matched controls
- 11349
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
Z85.3
ICD-10 Finland
Personal history of malignant neoplasm of breast
1002.3
323.0
644
15
115
Kela drug reimbursment
Breast cancer
14.7
282.4
540
661
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
12.9
195.2
378
422
HAC20
NOMESCO Finland
Total mastectomy
14.0
170.8
312
298
Z80.3
ICD-10 Finland
Family history of malignant neoplasm of breast
312.0
162.1
161
6
H02AB02
ATC
dexamethasone; systemic
8.6
158.5
393
658
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
10.0
153.6
339
463
A03FA01
ATC
metoclopramide; systemic, rectal
5.8
145.9
540
1537
L02BG04
ATC
letrozole; oral
9.4
144.9
332
479
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
10.9
141.0
292
349
PJA12
NOMESCO Finland
Sentinel node biopsy
7.9
132.8
343
591
HA1AA
NOMESCO Finland
X-ray mammography
8.0
130.8
332
555
Z85.7
ICD-10 Finland
Personal history of other malignant neoplasms of lymphoid, haematopoietic and related tissues
+∞
129.7
122
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
14.9
126.0
220
180
L02BA01
ATC
tamoxifen; oral
11.7
125.1
247
264
A04AA02
ATC
granisetron; systemic, transdermal
10.2
124.9
266
329
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
10.5
107.9
224
259
Z31.5
ICD-10 Finland
Genetic counselling
12.3
106.2
202
196
Z85.8
ICD-10 Finland
Personal history of malignant neoplasms of other organs and systems
1033.6
98.6
95
*
Z85.6
ICD-10 Finland
Personal history of leukaemia
+∞
98.4
93
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
3.6
86.0
590
2645
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
38.3
84.7
108
31
HA1CG
NOMESCO Finland
Extensive MRI examination of mammary gland with high intensity magnet
20.0
84.7
130
73
C91.0
ICD-10 Finland
Acute lymphoblastic leukaemia [ALL]
119.0
82.2
88
8
X76
ICPC
Malignant neoplasm breast female
13.7
77.5
138
113
TQW20
NOMESCO Finland
Tatoe
28.1
76.3
105
41
C50.99
ICD-10 Finland
Breast, unspecified
10.6
76.0
154
165
HAE10
NOMESCO Finland
Reconstruction of breast using graft or flap
20.6
75.3
114
61
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
6.7
74.8
208
370
C50
ICD-10 Finland
Malignant neoplasm of breast
10.8
74.4
149
156
HAB99
NOMESCO Finland
Other partial excision of mammary gland
11.5
73.3
142
139
Z85.0
ICD-10 Finland
Personal history of malignant neoplasm of digestive organs
72.5
71.3
81
12
9835/3-C42.1
ICD-O-3
Precursor cell lymphoblastic leukemia, NOS, of bone marrow
194.7
71.0
73
*
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
11.7
69.9
134
128
L03AA13
ATC
pegfilgrastim; parenteral
7.9
69.7
169
245
JN4BD
NOMESCO Finland
Extensive body CT
5.0
67.7
245
594
HAE20
NOMESCO Finland
Reconstruction of areola and mamilla using graft or flap
21.2
67.5
101
52
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
6.8
66.5
179
302
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
3.0
66.4
570
2827
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
3.8
63.8
320
1056
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.9
60.5
586
3078
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
13.6
59.8
106
85
8500/3-C50.4
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast
10.8
59.7
119
122
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
10.0
59.3
123
136
NK6AN
NOMESCO Finland
Total body bone isotope imaging
13.0
58.1
105
88
WF003
NOMESCO Finland
Adjuvant radiotherapy
8.9
58.0
129
161
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
6.1
57.3
167
310
L03AA02
ATC
filgrastim; parenteral
10.1
56.7
117
128
D05.1
ICD-10 Finland
Intraductal carcinoma in situ
10.5
55.1
111
116
HA013
NOMESCO Finland
Radiotherapy after total ablation of mammary gland
14.1
54.5
95
73
WX408
NOMESCO Finland
General anesthesy, balanced
3.0
54.0
414
1834
A04AA01
ATC
ondansetron; systemic, rectal
5.1
52.7
181
407
Z85.4
ICD-10 Finland
Personal history of malignant neoplasm of genital organs
278.2
52.6
53
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
3.0
51.6
372
1571
HA1AT
NOMESCO Finland
Biopsy of mammary glands with ultrasound guidance
9.3
51.0
110
130
HAB40
NOMESCO Finland
Wedge excision of mammary gland
5.0
50.3
176
403
C50.42
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor
10.4
47.6
96
100
C50.21
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor
8.1
46.3
108
145
L02BG06
ATC
exemestane; oral
11.0
45.1
88
86
L01BB02
ATC
mercaptopurine; oral
19.3
45.0
69
38
C50.81
ICD-10 Finland
Overall malignant tumor of the mammary gland, ductal tumor
11.0
44.1
86
84
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
5.3
43.9
144
305
NEA10
NOMESCO Finland
Exploration of soft tissue of pelvis, percutaneous
43.6
43.8
54
13
XX2AT
NOMESCO Finland
Other injection with ultrasound examination
13.7
43.4
76
59
C50.91
ICD-10 Finland
Malignant tumor in another specified localization in ductal mammary gland
11.1
42.8
83
80
A04AD12
ATC
aprepitant; systemic
9.0
41.7
91
109
THW99
NOMESCO Finland
Other minor procedure in surgery of mammary gland
8.3
41.6
95
123
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
16.3
40.0
65
42
C50.11
ICD-10 Finland
Malignant tumor of the central part of the mammary gland,ductal tumor
12.3
39.2
72
62
C50.90
ICD-10 Finland
Malignant tumor in other or unspecified location in mammary gland without histology
10.0
38.7
79
84
C50.51
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor
8.3
38.5
88
114
XX3DW
NOMESCO Finland
Time consuming IT work
3.7
38.5
186
571
TPX10
NOMESCO Finland
Implantation of vascular injection port
8.4
38.4
87
111
C81.1
ICD-10 Finland
Nodular sclerosis classical Hodgkin lymphoma
47.8
38.1
46
10
C50.40
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication
7.5
37.4
91
130
H02AB09
ATC
hydrocortisone; systemic
8.4
37.1
84
107
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
5.7
37.1
112
214
HAC15
NOMESCO Finland
Subcutaneous mastectomy with excision of mamilla
24.7
36.9
52
22
HAD30
NOMESCO Finland
Reduction mammoplasty with transposition of areola
5.9
36.9
108
199
L02BG03
ATC
anastrozole; oral
8.2
36.7
84
109
Z85.5
ICD-10 Finland
Personal history of malignant neoplasm of urinary tract
+∞
36.6
35
*
PJW99
NOMESCO Finland
Other operation on lymphatic system
24.8
35.6
50
21
B01AB05
ATC
enoxaparin; parenteral
2.4
35.1
396
2080
Z42.1
ICD-10 Finland
Follow-up care involving plastic surgery of breast
22.2
35.1
51
24
TAB00
NOMESCO Finland
Lumbar puncture
5.3
32.9
106
218
R50.9
ICD-10 Finland
Fever, unspecified
3.1
32.7
206
766
K11.71
ICD-10 Finland
Xerostomy (dry mouth)
13.3
31.9
56
44
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
9.4
31.5
66
74
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
8.2
28.7
65
83
HAE99
NOMESCO Finland
Other reconstruction of breast
15.9
28.3
46
30
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
10.3
28.2
56
57
Z40.0
ICD-10 Finland
Prophylactic surgery for risk-factors related to malignant neoplasms
102.6
27.8
30
*
HAE00
NOMESCO Finland
Reconstruction of breast using prosthesis
23.7
27.5
39
17
Z80.0
ICD-10 Finland
Family history of malignant neoplasm of digestive organs
+∞
27.2
26
*
8520/3-C50.9
ICD-O-3
Lobular carcinoma, NOS, of breast, NOS
7.6
26.8
64
89
XW000
NOMESCO Finland
Bone marrow biopsy
5.1
26.6
86
178
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.9
26.5
183
716
8500/2-C50.9
ICD-O-3
Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS
10.4
26.4
52
52
HA6AA
NOMESCO Finland
Extra corporeal mammography of operated mammary gland
4.7
26.1
93
213
9101
FHL
Bone biopsy
+∞
26.1
25
*
ZZR10
NOMESCO Finland
Flap of skin and muscle
13.7
26.1
45
34
Z95.0
ICD-10 Finland
Presence of electronic cardiac devices
74.4
25.9
29
*
D70.82
ICD-10 Finland
Drug-induced neutropenia
9.0
25.7
55
64
YG1CD
NOMESCO Finland
Very extensive CT examination of thorax for dose design of radiotherapy
16.3
25.6
41
26
ZX013
NOMESCO Finland
Radiotherapy with large shaped fields - SSD therapy
17.2
25.5
40
24
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
10.0
25.4
51
53
C50.49
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology
6.7
25.4
66
104
Z80.4
ICD-10 Finland
Family history of malignant neoplasm of genital organs
+∞
25.1
24
*
Z85.9
ICD-10 Finland
Personal history of malignant neoplasm, unspecified
+∞
25.1
24
*
HAE05
NOMESCO Finland
Reconstruction of breast using soft tissue and prosthesis
17.5
25.0
39
23
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
3.0
24.9
158
582
EP1AE
NOMESCO Finland
Neck ultrasound examination
3.8
24.8
109
305
127
Kela drug reimbursment
Transplant complication
132.9
24.7
26
*
HA1BG
NOMESCO Finland
MRI examination of mammary gland with high intensity magnet
13.1
24.5
43
34
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
3.3
24.5
130
424
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.1
24.2
146
520
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
9.5
24.2
50
55
I97.2
ICD-10 Finland
Postmastectomy lymphoedema syndrome
18.2
24.1
37
21
2040A
ICD-9 Finland
Lymphoid leukaemia, Acute
+∞
24.0
23
*
HA6BA
NOMESCO Finland
Breast tomosynthesis specimen
8.6
23.8
52
63
N02BE01
ATC
paracetamol; systemic, rectal
2.3
23.7
979
8295
JN4AD
NOMESCO Finland
Body CT examination
3.5
23.3
115
354
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
4.5
23.1
84
197
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
10.8
23.0
44
42
602
Kela drug reimbursment
Children's severe malnutrition
85.2
22.7
25
*
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
13.4
22.5
39
30
X21
ICPC
Breast sympt/compl female other
6.3
22.4
60
99
ZSH00
NOMESCO Finland
Procedure related to previous procedure classified in chapter H
14.7
22.2
37
26
Z97.4
ICD-10 Finland
Presence of external hearing-aid
+∞
21.9
21
*
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
3.5
21.9
109
338
WZC30
NOMESCO Finland
Teaching
2.6
21.3
174
744
JN4CD
NOMESCO Finland
Very extensive body CT
4.8
21.1
72
158
ZZF00
NOMESCO Finland
Graft of adipose tissue
12.7
20.9
37
30
Z96.1
ICD-10 Finland
Presence of intraocular lens
6.4
20.8
55
89
A41.9
ICD-10 Finland
Sepsis, unspecified
5.5
20.8
62
117
C77.3
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Axillary and upper limb lymph nodes
42.5
20.5
25
6
HA1CM
NOMESCO Finland
Mammary gland extensive MRI examination with 3 Tesla magnet
26.0
20.5
28
11
HA3AT
NOMESCO Finland
Pucture of mammary gland cyst with ultrasound examination
13.3
20.3
35
27
HAB00
NOMESCO Finland
Excision of lesion of mammary gland
4.9
20.3
68
147
ZX120
NOMESCO Finland
Intravenous
2.9
20.0
132
499
L03AA10
ATC
lenograstim; parenteral
+∞
19.8
19
*
A04AA55
ATC
palonosetron, combinations; systemic
4.2
19.7
76
189
HA1BA
NOMESCO Finland
Extensive X-ray mammography
12.0
19.3
35
30
J01MA12
ATC
levofloxacin; systemic
2.2
19.3
210
1040
TQB05
NOMESCO Finland
Puncture of skin of trunk
9.2
19.2
40
45
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
4.8
19.2
65
142
Z31.6
ICD-10 Finland
General counselling and advice on procreation
17.5
18.8
29
17
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
3.1
18.3
105
361
ZZQ10
NOMESCO Finland
Free microvascular graft of skin and muscle
19.7
18.2
27
14
N62
ICD-10 Finland
Hypertrophy of breast
3.7
18.0
80
226
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
4.7
17.9
62
139
L03AA14
ATC
lipegfilgrastim; parenteral
5.9
17.8
50
88
Z92.6
ICD-10 Finland
Personal history of chemotherapy for neoplastic disease
+∞
17.7
17
*
Z80.8
ICD-10 Finland
Family history of malignant neoplasm of other organs or systems
+∞
17.7
17
*
HAD60
NOMESCO Finland
Replacement of prosthetic implant in breast
37.3
17.6
22
6
8520/3-C50.4
ICD-O-3
Lobular carcinoma, NOS, of upper-outer quadrant of breast
11.7
17.6
32
28
K03.66
ICD-10 Finland
Tooth plaque
2.9
17.6
110
401
C50.31
ICD-10 Finland
Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor
7.6
17.6
41
56
QBE20
NOMESCO Finland
Excision and repair of scar or web of skin of trunk
10.9
17.5
33
31
Z95.5
ICD-10 Finland
Presence of coronary angioplasty implant and graft
42.7
17.3
21
5
ZXA00
NOMESCO Finland
Right side
1.9
17.2
313
1899
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
4.0
17.2
69
179
C81.9
ICD-10 Finland
Hodgkin lymphoma, unspecified
32.0
17.1
22
7
8500/3-C50.2
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-inner quadrant of breast
8.5
17.1
37
45
WW500
NOMESCO Finland
Blood transfusion
4.0
17.1
69
180
Z01.6
ICD-10 Finland
Radiological examination, not elsewhere classified
2.5
17.0
140
599
QBE30
NOMESCO Finland
Excision and repair of surgical scar in trunk
12.3
16.9
30
25
Z95.1
ICD-10 Finland
Presence of aortocoronary bypass graft
64.3
16.8
19
*
Z85.1
ICD-10 Finland
Personal history of malignant neoplasm of trachea, bronchus and lung
+∞
16.7
16
*
PJ3AT
NOMESCO Finland
Cytology of lymphnode with ultrasound guidance
8.1
16.6
37
47
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
3.4
16.6
84
264
WX704
NOMESCO Finland
Intubation
3.1
16.5
94
321
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
3.7
16.5
74
211
HAA10
NOMESCO Finland
Biopsy of mammary gland
9.7
16.5
33
35
TPH04
NOMESCO Finland
Cathetrisation of vein
2.0
16.4
229
1253
HWA00
NOMESCO Finland
Repair of wound dehiscence in surgery of mammary gland
24.9
16.0
22
9
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
9.1
16.0
33
37
XX1AT
NOMESCO Finland
Other puncture with ultrasound guidance
9.4
15.7
32
35
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
3.4
15.7
77
237
C50.4
ICD-10 Finland
Malignant neoplasm: Upper-outer quadrant of breast
7.6
15.2
35
47
D24
ICD-10 Finland
Benign neoplasm of breast
4.8
15.2
50
107
PJD42
NOMESCO Finland
Excision of axillary lymph nodes
6.5
15.1
39
62
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
6.2
15.1
40
66
A02BC01
ATC
omeprazole; systemic
1.8
15.1
311
1955
PJA10
NOMESCO Finland
Exploration of lymph nodes
8.1
14.9
33
42
XX9CD
NOMESCO Finland
Very extensive complementary CT
32.1
14.8
19
6
LAF11
NOMESCO Finland
Laparoscopic bilateral salpingo-oophorectomy
2.9
14.8
95
352
A02BC02
ATC
pantoprazole; systemic
1.7
14.8
697
5559
SPAT1153
SPAT
Removal of sutures
1.8
14.7
348
2287
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
+∞
14.6
14
*
1XC02
NOMESCO Finland
NA
12.1
14.6
26
22
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.6
14.5
107
429
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.1
14.5
169
856
L01BC06
ATC
capecitabine; oral
3.8
14.4
61
166
N64.5
ICD-10 Finland
Other signs and symptoms in breast
4.5
14.3
50
114
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
5.6
14.3
41
75
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
2.8
14.0
90
333
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
3.4
13.9
68
209
Z98.8
ICD-10 Finland
Other specified postsurgical states
30.4
13.9
18
6
C50.89
ICD-10 Finland
Overall malignant tumor of the mammary gland, other or undeterminated histology
8.3
13.8
30
37
HAB50
NOMESCO Finland
Partial excision of mammary gland with reconstructive operation
4.2
13.8
52
128
C50.82
ICD-10 Finland
Overall malignant tumor of the mammary gland, lobular tumor
7.4
13.8
32
44
WD205
NOMESCO Finland
Therapy of methastized malignancy with hormones
9.8
13.7
27
28
N02AA05
ATC
oxycodone; systemic
2.2
13.6
155
777
H25.8
ICD-10 Finland
Other senile cataract
2.5
13.6
108
454
ZX131
NOMESCO Finland
Intrathecal
+∞
13.6
13
*
HWH99
NOMESCO Finland
Other reoperation in surgery of mammary gland
13.0
13.4
23
18
HAD40
NOMESCO Finland
Mastopexy
13.0
13.4
23
18
ZXE30
NOMESCO Finland
More than five and less than seven hours
3.3
13.3
68
216
9707
FHL
Ablation of mammae and removal of axillary lymph nodes
8.7
13.3
28
33
1744A
ICD-9 Finland
Malignant neoplasm of female breast, Upper-outer quadrant
8.7
13.3
28
33
ZXE40
NOMESCO Finland
More than seven and less than nine hours
5.3
13.3
40
78
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
4.4
13.0
46
107
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.5
12.9
107
461
ZXA05
NOMESCO Finland
Left side
1.8
12.8
273
1724
HAC25
NOMESCO Finland
Radical mastectomy
12.4
12.6
22
18
130
Kela drug reimbursment
Malignant tumour
2.6
12.6
95
386
-59
ICPC
Other therap proced/minor surg NEC
4.4
12.5
45
106
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
7.4
12.5
29
40
E89.4
ICD-10 Finland
Postprocedural ovarian failure
+∞
12.5
12
*
2301
FHL
Lumbar puncture in anesthesia or operating room
+∞
12.5
12
*
9663/3-C77.8
ICD-O-3
Hodgkin lymphoma, nodular sclerosis, NOS, of lymph nodes of multiple regions
131.3
12.5
13
*
ZSZ10
NOMESCO Finland
Secondary repair operation
131.3
12.5
13
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
5.7
12.1
34
61
HWD00
NOMESCO Finland
Reoperation for deep haemorrhage in surgery of mammary gland
8.8
12.0
25
29
HAD99
NOMESCO Finland
Other plastic operation on breast
10.2
12.0
23
23
J01DB01
ATC
cefalexin; oral
1.7
11.9
895
7823
Z95.2
ICD-10 Finland
Presence of prosthetic heart valve
47.1
11.9
14
*
Z01.8
ICD-10 Finland
Other specified special examinations
1.8
11.9
231
1413
D48.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Breast
4.5
11.8
41
94
C50.00
ICD-10 Finland
Malignant tumor of nipple and areola, no histological veryfication
9.8
11.8
23
24
8500/3-C50.5
ICD-O-3
Infiltrating duct carcinoma, NOS, of lower-outer quadrant of breast
7.4
11.7
27
37
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
3.6
11.7
52
149
C92.0
ICD-10 Finland
Acute myeloblastic leukaemia [AML]
16.6
11.7
18
11
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.3
11.7
107
484
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
2.0
11.6
151
798
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
8.2
11.6
25
31
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
2.8
11.6
75
278
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.6
11.6
450
3336
SPAT1286
SPAT
Assessment of operability, including opinions
23.1
11.6
16
7
UJF32
NOMESCO Finland
Coloscopy
1.7
11.5
273
1771
H02AB06
ATC
prednisolone; systemic
1.6
11.5
492
3733
A46
ICD-10 Finland
Erysipelas
2.1
11.3
131
660
M05BX04
ATC
denosumab; parenteral
2.8
11.2
74
280
WX702
NOMESCO Finland
Supraglottic ventilation device
2.7
11.1
76
292
JN3CG
NOMESCO Finland
Extensive MRI examination of abdomen with high intensity magnet
11.3
11.1
20
18
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.1
10.9
127
642
ZZQ00
NOMESCO Finland
Free microvascular graft of skin
12.0
10.9
19
16
HAD50
NOMESCO Finland
Removal of prosthetic implant from breast
12.0
10.9
19
16
N63
ICD-10 Finland
Unspecified lump in breast
2.2
10.7
108
511
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
4.8
10.6
34
72
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
2.0
10.6
143
764
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
4.2
10.5
39
96
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.6
10.5
297
2021
C50.09
ICD-10 Finland
Malignant tumor of nipple and areola, other or undeterminated histology
110.9
10.4
11
*
L01BB03
ATC
tioguanine; oral
+∞
10.4
10
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
4.6
10.4
35
78
ZXE20
NOMESCO Finland
More than three and less than five hours
2.0
10.4
140
751
QBJ00
NOMESCO Finland
Liposuction in trunk
12.2
10.4
18
15
C50.50
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, no histological veryfication
13.2
10.2
17
13
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
6.0
10.2
27
46
UJF30
NOMESCO Finland
Ileoscopy through colon
2.1
10.0
113
563
XFP20
NOMESCO Finland
Check up of cardiac pacemaker
4.3
10.0
36
86
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
7.3
10.0
23
32
SPAT1312
SPAT
General health counselling
1.6
10.0
355
2553
9109
FHL
Other measure in this category
40.4
10.0
12
*
WC205
NOMESCO Finland
Simple therapy of local tumor recidive with hormone
40.4
10.0
12
*
C91.9
ICD-10 Finland
Lymphoid leukaemia, unspecified
26.2
9.8
13
5
HA1SA
NOMESCO Finland
Expansion mammography
8.8
9.8
20
23
LCA06
NOMESCO Finland
Biopsy of endometrium
1.8
9.7
162
939
SPAT1149
SPAT
Suture or treatment of traumatic wound
2.0
9.7
125
659
Z03.8
ICD-10 Finland
Observation for other suspected diseases and conditions
2.8
9.6
61
226
L02BA03
ATC
fulvestrant; parenteral
7.9
9.6
21
27
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.9
9.5
139
767
HAC10
NOMESCO Finland
Subcutaneous mastectomy with preservation of mamilla
15.2
9.5
15
10
Z3231
NOMESCO Finland
Registered nurse
1.6
9.5
286
1969
9663/3-C77.0
ICD-O-3
Hodgkin lymphoma, nodular sclerosis, NOS, of lymph nodes of head, face and neck
100.8
9.4
10
*
C81.0
ICD-10 Finland
Nodular lymphocyte predominant Hodgkin lymphoma
30.3
9.4
12
*
PJ1AN
NOMESCO Finland
Lymphsystem isotope imaging
17.7
9.4
14
8
Z94.0
ICD-10 Finland
Kidney transplant status
+∞
9.4
9
*
T81.8
ICD-10 Finland
Other complications of procedures, not elsewhere classified
4.6
9.3
31
69
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.7
9.3
202
1270
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
2.3
9.3
84
379
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
6.1
9.2
24
40
TPW99
NOMESCO Finland
Other minor surgical procedure on peripheral vessel or lymphatic system
6.1
9.2
24
40
C50.29
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland, other or undeterminated histology
6.1
9.2
24
40
J01FF01
ATC
clindamycin; systemic
1.6
9.2
269
1839
CS494
NOMESCO Finland
Other visual field testing
4.4
9.1
32
75
ZX090
NOMESCO Finland
Other technic of radiotherapy
3.3
9.1
44
136
N05CF01
ATC
zopiclone; oral
1.6
9.1
324
2319
WB401
NOMESCO Finland
Simple antibody therapy of primary tumour
4.6
9.1
30
66
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.9
9.1
139
779
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
8.4
9.1
19
23
J05AB11
ATC
valaciclovir; oral
1.8
9.0
151
871
C50.19
ICD-10 Finland
Malignant tumor of the central part of the mammary gland, other or undeterminated histology
10.1
9.0
17
17
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
7.5
8.9
20
27
C50.22
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,lobular tumor
6.4
8.8
22
35
ZX121
NOMESCO Finland
Central venous catheter
10.8
8.8
16
15
J01MA02
ATC
ciprofloxacin; systemic
1.5
8.8
368
2733
A06AD11
ATC
lactulose; oral
1.9
8.7
133
745
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
1.5
8.7
326
2358
C03CA01
ATC
furosemide; systemic
1.6
8.7
232
1545
KA1MN
NOMESCO Finland
Glomerular filtration rate (GFR) Isotope mesurement
50.4
8.7
10
*
C81.7
ICD-10 Finland
Other classical Hodgkin lymphoma
50.4
8.7
10
*
D89.89
ICD-10 Finland
Other specified disorders involving the immune mechanism, not elsewhere classified
50.4
8.7
10
*
Z01.4
ICD-10 Finland
Gynaecological examination (general)(routine)
1.7
8.7
201
1286
H03AA01
ATC
levothyroxine sodium; systemic
1.6
8.7
284
1990
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.7
8.6
182
1136
HAD10
NOMESCO Finland
Augmentation of breast using prosthesis
11.7
8.6
15
13
L02AE03
ATC
goserelin; implant
4.8
8.6
27
57
D38.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Mediastinum
16.4
8.6
13
8
SPAT1269
SPAT
Other puncture and/or drainage
10.1
8.5
16
16
9663/3-C77.9
ICD-O-3
Hodgkin lymphoma, nodular sclerosis, NOS, of lymph node, NOS
27.7
8.5
11
*
121
Kela drug reimbursment
Severe hypofunction of sexual glands
3.8
8.5
34
91
R1220
NOMESCO Finland
Psychological examination of need and possibilities to rehabilitation
6.0
8.5
22
37
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.6
8.4
288
2038
WX1DG
NOMESCO Finland
Very extensive total body MRI with high intensity magnet
90.7
8.4
9
*
WW402
NOMESCO Finland
Leucoferesis
90.7
8.4
9
*
HA4AT
NOMESCO Finland
Labeling mammary gland pathology with ultrasound guidance
2.9
8.4
49
173
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
12.9
8.4
14
11
Z96.6
ICD-10 Finland
Presence of orthopaedic joint implants
8.6
8.3
17
20
ZX112
NOMESCO Finland
Subcutaneous
3.7
8.3
35
98
BA3AT
NOMESCO Finland
Cytology of thyroid with ultrasound quidance
4.1
8.3
31
78
KFC00
NOMESCO Finland
Unilateral orchiectomy
14.6
8.2
13
9
A79
ICPC
Malignancy NOS
5.2
8.2
24
47
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.9
8.2
112
605
L01CA04
ATC
vinorelbine; systemic
7.6
8.2
18
24
-44
ICPC
Preventive immunization/medic
2.1
8.2
95
480
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
2.4
8.1
65
275
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
4.1
8.1
30
75
SAA03
NOMESCO Finland
Extended examination of mouth
1.5
8.1
417
3224
5604
FHL
Vascular preparation or cannulation in the operating room
17.3
8.1
12
7
1501
Kela drug reimbursment
Palbociclib
6.9
8.1
19
28
WX402
NOMESCO Finland
General anaesthesia
1.7
8.1
180
1138
A07AA02
ATC
nystatin; oral
2.3
8.1
74
338
K00.40
ICD-10 Finland
Postnatal enamel hypoplasia
7.3
8.0
18
25
Z10.8
ICD-10 Finland
Routine general health check-up of other defined subpopulations
2.6
8.0
58
234
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.4
7.9
542
4418
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
2.1
7.9
87
430
SCA02
NOMESCO Finland
Analysis and advice of nutrition with regard to dentistry
1.9
7.9
124
700
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
1.8
7.8
141
835
ZXD00
NOMESCO Finland
Emergency procedure
3.2
7.8
39
125
C50.10
ICD-10 Finland
Malignant tumor of the central part of the mammary gland, no histological veryfication
9.5
7.8
15
16
QX3AT
NOMESCO Finland
Ultrasound guided biopsy of subcutaneous tissue
7.0
7.8
18
26
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
2.2
7.8
81
390
8140/3-C20.9
ICD-O-3
Adenocarcinoma, NOS, of rectum, NOS
4.5
7.8
26
59
D48.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bone and articular cartilage
5.1
7.7
23
46
C83.33
ICD-10 Finland
Primary medical lymphoma with large B cells
45.3
7.7
9
*
TPX15
NOMESCO Finland
Removal of vascular injection port
11.9
7.6
13
11
ZSP00
NOMESCO Finland
Procedure related to previous procedure classified in chapter P
25.2
7.6
10
*
QBE00
NOMESCO Finland
Excision of loose skin or fold of skin from trunk
8.9
7.5
15
17
S18
ICPC
Laceration/cut
1.4
7.5
408
3174
NK6MA
NOMESCO Finland
Measurement of bone age from hand and elbow using X-ray
5.8
7.5
20
35
C50.80
ICD-10 Finland
Overall malignant tumor of the mammary gland, no histological veryfication
10.1
7.5
14
14
C73.91
ICD-10 Finland
Papillary carcinoma of the thyroid gland (thyroid gland)
4.2
7.5
27
66
Z04.9
ICD-10 Finland
Examination and observation for unspecified reason
2.5
7.5
55
223
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
7.2
7.5
17
24
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.8
7.5
133
785
NE1CG
NOMESCO Finland
Pelvic, hip and femur extensive MRI examination with high intensity magnet
3.9
7.5
29
76
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.1
7.4
83
411
C96.9
ICD-10 Finland
Malignant neoplasm of lymphoid, haematopoietic and related tissue, unspecified
80.6
7.4
8
*
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
4.6
7.4
24
53
8500/3-C50.3
ICD-O-3
Infiltrating duct carcinoma, NOS, of lower-inner quadrant of breast
7.7
7.4
16
21
C50.12
ICD-10 Finland
Malignant tumor of the central part of the mammary gland,lobular tumor
7.7
7.4
16
21
8500/3-C50.8
ICD-O-3
Infiltrating duct carcinoma, NOS, of overlapping lesion of breast
13.5
7.4
12
9
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
3.8
7.4
29
77
8500/3-C50.1
ICD-O-3
Infiltrating duct carcinoma, NOS, of central portion of breast
8.4
7.3
15
18
8260/3-C73.9
ICD-O-3
Papillary adenocarcinoma, NOS, of thyroid gland
4.2
7.3
26
63
192
Kela drug reimbursment
Fulvestrant
6.9
7.3
17
25
5639
FHL
Other measure in this category
+∞
7.3
7
*
Z93.3
ICD-10 Finland
Colostomy status
+∞
7.3
7
*
Z85.2
ICD-10 Finland
Personal history of malignant neoplasm of other respiratory and intrathoracic organs
+∞
7.3
7
*
HA1TE
NOMESCO Finland
Supplementary or limited ultrasound examination of mammary glands
5.0
7.3
22
45
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.4
7.3
424
3342
C50.52
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, lobular tumor
6.3
7.2
18
29
A40.8
ICD-10 Finland
Other streptococcal sepsis
15.8
7.2
11
7
LC2DE
NOMESCO Finland
Demanding ultrsound examination of uterus, parametrium and lower part of abdomen with speciel methods
2.4
7.2
58
249
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
5.8
7.2
19
33
N03AX16
ATC
pregabalin; oral
1.6
7.2
232
1611
WX882
NOMESCO Finland
High dependency care
3.4
7.2
33
100
I80.8
ICD-10 Finland
Phlebitis and thrombophlebitis of other sites
4.9
7.2
22
46
TPH07
NOMESCO Finland
Cathetrisation of artery
2.0
7.2
94
500
ZZS55
NOMESCO Finland
Distension of tissue expander
30.2
7.2
9
*
QCJ00
NOMESCO Finland
Liposuction in upper limb
30.2
7.2
9
*
Z48.9
ICD-10 Finland
Surgical follow-up care, unspecified
20.1
7.1
10
5
HAD00
NOMESCO Finland
Augmentation mammoplasty
20.1
7.1
10
5
C50.20
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,no histological veryfication
5.7
7.1
19
34
GD1AD
NOMESCO Finland
Thorax CT examination
2.7
7.0
45
169
C50.2
ICD-10 Finland
Malignant neoplasm: Upper-inner quadrant of breast
7.0
7.0
16
23
X19
ICPC
Breast lump/mass female
3.6
7.0
29
81
QDE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in lower limb
2.9
7.0
40
140
C50.9
ICD-10 Finland
Malignant neoplasm: Breast, unspecified
6.4
6.9
17
27
394
Kela drug reimbursment
Palbociclib
6.4
6.9
17
27
K07.30
ICD-10 Finland
Spacing, abnormal of tooth or teeth
3.1
6.9
36
120
C50.93
ICD-10 Finland
Malignant tumor in other specified localization in mammary gland other or unspecified histology
13.9
6.9
11
8
N61
ICD-10 Finland
Inflammatory disorders of breast
3.2
6.9
34
109
C50.39
ICD-10 Finland
Malignant tumor of the lower inner quadrant of the mammary gland, other or undeterminated histology
11.0
6.8
12
11
8140/3-C18.7
ICD-O-3
Adenocarcinoma, NOS, of sigmoid colon
6.1
6.8
17
28
HAD20
NOMESCO Finland
Liposuction of breast
16.8
6.7
10
6
0388X
ICD-9 Finland
Septicaemia, Other specified septicaemias
22.6
6.7
9
*
A11CC03
ATC
alfacalcidol; systemic
4.5
6.7
22
50
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.6
6.7
165
1072
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
2.3
6.6
59
267
B01.9
ICD-10 Finland
Varicella without complication
8.7
6.6
13
15
N06AX16
ATC
venlafaxine; oral
1.7
6.5
141
883
K02.0
ICD-10 Finland
Caries limited to enamel
1.7
6.5
153
978
R19.0
ICD-10 Finland
Intra-abdominal and pelvic swelling, mass and lump
2.7
6.5
40
149
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
2.3
6.5
55
242
20400
ICD-8 Finland
Lymphatic leukaemia, Acute
70.2
6.4
7
*
Z80.9
ICD-10 Finland
Family history of malignant neoplasm, unspecified
70.2
6.4
7
*
1890A
ICD-9 Finland
Malignant neoplasm of kidney and other and unspecified urinary organs, Kidney, except pelvis[NEOPL MAL RENIS PELVI EXCEPTO,NEPHROBLASTOMA]
70.2
6.4
7
*
-31
ICPC
Medical examin/health eval partial
2.0
6.4
80
416
L01XE33
ATC
[U] palbociclib; oral
7.4
6.4
14
19
Z3226
NOMESCO Finland
Physiotherapist
1.6
6.4
186
1260
C50.1
ICD-10 Finland
Malignant neoplasm: Central portion of breast
14.4
6.4
10
7
GD2SN
NOMESCO Finland
Lung ventilation SPECT
14.4
6.4
10
7
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
3.4
6.4
29
88
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
2.5
6.4
48
198
1CD02
NOMESCO Finland
NA
4.4
6.4
21
48
SPAT1263
SPAT
Sampling
1.4
6.3
431
3470
XF400
NOMESCO Finland
ECG with 12 standard connections
1.6
6.3
148
948
D40.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Testis
11.1
6.3
11
10
B02.9
ICD-10 Finland
Zoster without complication
2.2
6.3
62
295
JN3DG
NOMESCO Finland
Very extensive MRI examination with high intensity magnet
18.1
6.3
9
5
1XX02
NOMESCO Finland
NA
+∞
6.3
6
*
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
+∞
6.3
6
*
5609
FHL
Other measure in this category
+∞
6.3
6
*
KFH50
NOMESCO Finland
Insertion of prosthetic replacement for testis
+∞
6.3
6
*
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
2.2
6.2
59
275
NK1AT
NOMESCO Finland
Muscle biopsy with ultrasound guidance
26.8
6.2
8
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
2.2
6.2
63
300
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.8
6.2
103
595
R60.0
ICD-10 Finland
Localized oedema
1.8
6.2
99
565
SPAT1254
SPAT
Administration of medicine
1.6
6.1
148
957
Z51.88
ICD-10 Finland
Other specified medical care
3.6
6.1
25
70
V03AE01
ATC
polystyrene sulfonate; oral
12.6
6.1
10
8
WX110
NOMESCO Finland
Local anesthesy
1.4
6.1
706
6196
SPAT1215
SPAT
Assessment of need for medical rehabilitation
2.4
6.1
49
210
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
1.7
6.1
119
727
128
Kela drug reimbursment
Cancers of female genital organs
3.2
6.0
29
92
5702
FHL
Local lymph node removal (eg armpit, groin)
10.1
6.0
11
11
JN6DR
NOMESCO Finland
PET-CT of whole body metabolism
10.1
6.0
11
11
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
996
5673
3.74
108.18
9.7
5.6
umol/l
9.6
10.7
2.91
974
5356
(40768793) Breast Pathology biopsy report
196
371
5.99
101.19
1.5
1.3
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
1235
8643
5.21
88.20
11.9
6.7
u/l
81.2
79.0
0.45
1208
8077
(4035726)
308
985
3.74
81.55
1.4
1.3
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
148
264
6.16
80.77
2.4
1.4
u/l
9.4
11.5
0.94
120
202
(3044640) Blood type and Crossmatch panel - Blood
658
3428
2.76
73.44
3.1
2.2
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
1016
6637
3.03
72.40
14.5
8.6
e9/l
3.5
3.9
8.85
942
5767
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
310
1111
3.31
67.69
4.2
4.0
ug/l
6.4
20.0
1.60
254
902
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
103
169
6.51
60.81
1.7
1.5
nmol/l
0.3
0.3
0.20
88
131
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
815
5061
2.50
58.75
4.4
3.7
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
679
3952
2.42
55.51
4.7
3.2
mmol/l
2.4
2.4
0.09
592
3446
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
86
132
6.88
54.04
2.1
1.5
ug/l
2.4
3.1
0.91
71
116
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
851
5543
2.40
52.87
10.0
5.5
mmol/l
1.2
1.2
0.86
758
4696
(1617658) Protocol used for examination of sentinel lymph nodes
76
134
5.94
41.60
1.0
1.0
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
468
2557
2.26
41.46
4.5
3.7
—
—
—
0
0
(3019225) pH of Specimen
258
1090
2.68
40.19
5.8
3.3
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
255
1073
2.69
40.03
5.1
3.9
u/l
241.0
247.8
0.27
239
1013
(42870588) Differential panel, method unspecified - Blood
613
3767
2.13
40.00
7.0
5.5
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
757
5041
2.12
39.89
8.5
4.9
mmol/l
1.2
1.2
0.30
692
4512
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
467
2596
2.21
39.25
3.1
2.1
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
58
84
7.16
38.35
3.3
2.7
mg/l
46.4
14.0
1.01
45
54
(3023323) Follitropin [Units/volume] in Serum or Plasma
162
549
3.21
37.59
2.3
1.4
iu/l
19.2
30.5
4.62
139
459
(40768804) Tissue Pathology biopsy report
715
4746
2.06
37.00
2.7
2.0
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
768
5291
2.02
35.15
8.1
5.9
%
8.5
8.4
0.37
719
4930
(3006504) Eosinophils/100 leukocytes in Blood
761
5267
2.00
33.90
7.8
5.6
%
2.9
2.8
0.25
713
4884
(3002030) Lymphocytes/100 leukocytes in Blood
781
5455
2.00
33.88
7.9
5.7
%
28.2
29.1
1.41
732
5062
(3018010) Neutrophils/100 leukocytes in Blood
771
5372
1.99
33.56
7.6
5.5
%
56.6
56.4
0.14
724
5004
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
47
63
7.69
33.24
1.1
1.3
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
740
5124
1.96
32.35
7.9
5.7
%
0.6
0.7
1.17
692
4758
(40768795) Lymph node Pathology biopsy report
57
101
5.84
31.00
1.2
1.2
—
—
—
0
0
(40758558) Short blood count panel - Blood
492
3002
1.99
30.72
13.5
6.3
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
597
3897
1.94
30.54
7.6
6.9
inr
1.2
1.2
0.62
122
1078
(3002256) Pathology report gross observation
284
1417
2.27
30.06
1.4
1.2
—
—
—
0
0
(3013512) EKG study
498
3081
1.97
29.65
4.9
3.4
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
459
2787
1.97
28.67
3.4
2.5
ng/l
1378.5
995.1
0.61
384
2315
(3013115) Eosinophils [#/volume] in Blood
802
5842
1.89
28.65
8.3
5.8
e9/l
0.2
0.2
0.77
735
5099
(3019198) Lymphocytes [#/volume] in Blood
795
5790
1.88
28.25
7.7
5.5
e9/l
1.7
2.0
5.92
734
5070
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
551
3578
1.90
27.99
4.5
3.0
u/l
29.5
33.3
0.86
533
3402
(3001604) Monocytes [#/volume] in Blood
776
5622
1.87
27.89
7.6
5.5
e9/l
0.6
0.6
0.17
704
4816
(3006315) Basophils [#/volume] in Blood
777
5639
1.87
27.69
7.6
5.5
e9/l
0.0
0.0
3.56
703
4845
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
71
169
4.38
27.50
1.3
1.2
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
100
305
3.46
27.33
1.2
1.2
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
670
4678
1.84
26.67
5.7
4.1
g/l
35.5
35.9
1.22
629
4342
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
1230
10653
2.47
24.07
18.0
11.3
ml/min/173m2
83.1
81.9
1.01
1000
8535
(3042936) Bacteria identified in Isolate by Culture
258
1368
2.09
22.88
2.0
1.8
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
682
4949
1.75
22.47
2.6
2.3
nmol/l
77.1
78.4
0.63
608
4428
(3013826) Glucose [Moles/volume] in Serum or Plasma
814
6236
1.75
21.88
5.7
4.0
mmol/l
6.5
6.6
0.56
764
5783
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
281
1566
2.00
21.63
1.8
1.7
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
1032
8500
1.86
21.36
5.4
4.0
mm/h
12.3
12.1
0.19
962
7853
(3045781) Inhibin B [Mass/volume] in Serum or Plasma
27
32
8.59
21.06
2.6
2.2
ng/l
99.1
125.2
0.54
22
23
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
36
62
5.94
20.15
2.3
2.2
e6/l
462.2
736.6
—
6
21
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
197
991
2.15
19.87
2.2
2.1
g/l
0.2
0.2
1.27
190
931
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
248
1368
1.99
19.48
4.4
4.4
%
34.4
32.8
1.27
155
878
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
98
363
2.83
19.23
1.9
1.8
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
1274
11444
2.54
18.91
19.8
11.8
mg/l
21.8
22.2
0.22
1089
8747
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
40
81
5.06
18.84
1.1
1.1
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
229
1256
1.99
18.20
2.7
2.1
%
20.7
23.2
2.24
197
1087
(3012095) Magnesium [Moles/volume] in Serum or Plasma
275
1605
1.89
18.17
5.5
2.8
mmol/l
0.8
0.8
0.28
260
1483
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
165
805
2.19
17.90
3.4
3.6
u/ml
45.1
62.2
0.61
154
776
(3004789) Transferrin [Mass/volume] in Serum or Plasma
242
1367
1.93
17.61
2.6
2.0
g/l
2.4
2.4
0.36
228
1255
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1323
12180
3.28
17.38
16.0
9.6
u/l
25.4
24.5
1.11
1304
11724
(21494815) CD4 cells/100 lymphocytes in Specimen
38
79
4.92
17.37
2.6
1.9
—
42.4
—
0
11
(3045142) Bone marrow Pathology biopsy report
47
118
4.09
17.01
1.3
1.3
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
944
7830
1.66
16.19
4.9
4.2
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
1286
11754
2.45
15.63
22.7
13.5
mmol/l
3.9
3.9
0.23
1265
11402
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
87
339
2.67
15.50
1.9
1.7
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
252
1502
1.83
15.37
2.7
2.1
umol/l
12.4
13.4
1.33
236
1377
(3021879) Hepatitis B virus core Ab [Presence] in Serum
150
760
2.09
14.70
1.4
1.3
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
96
403
2.49
14.69
2.1
1.9
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
900
7465
1.59
14.58
5.2
4.4
e6/l
916.9
2713.0
—
9
100
(3027945) Reticulocytes/100 erythrocytes in Blood
195
1090
1.92
14.48
4.9
2.7
%
1.7
1.8
0.84
170
968
(40761511) CBC panel - Blood by Automated count
1296
11942
2.48
14.46
18.4
11.1
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
1280
11734
2.31
14.43
22.4
13.4
mmol/l
139.7
139.7
0.13
1265
11407
(3011412) CD3 cells [#/volume] in Blood
37
89
4.24
14.19
2.3
2.3
e9/l
1.5
1.1
1.97
27
56
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
33
74
4.54
13.81
2.6
2.1
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
39
101
3.94
13.57
5.4
3.3
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
86
356
2.51
13.56
3.2
1.9
nmol/l
12.1
11.8
0.14
80
309
(3009542) Hematocrit [Volume Fraction] of Blood
1180
10572
1.82
13.35
23.4
13.4
%
37.3
39.4
9.05
872
7690
(3045424) Erythrocytes [Presence] in Urine
52
166
3.22
13.25
1.3
1.4
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
52
167
3.20
13.13
1.7
1.4
u/l
31.9
29.5
0.19
45
139
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
117
564
2.17
13.02
1.6
1.6
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
14
13
10.87
12.87
3.5
3.4
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
30
66
4.62
12.86
7.6
3.0
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
519
3895
1.53
12.51
4.2
3.1
ng/l
28.2
165.2
0.55
389
2470
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
32
76
4.29
12.49
2.4
2.1
%
8.9
11.6
1.06
24
38
(3017143) Hepatitis C virus Ab [Presence] in Serum
201
1191
1.81
12.33
1.6
1.4
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
56
199
2.89
11.90
3.5
2.6
mmol/l
7.5
7.5
0.04
56
192
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
858
7200
1.51
11.84
3.6
2.9
u/l
47.0
42.3
0.78
793
6674
(3051611) Lipemic interference index of Serum or Plasma
40
117
3.49
11.72
6.8
2.8
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
19
30
6.41
11.56
1.1
1.5
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
19
30
6.41
11.56
1.1
1.5
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
19
30
6.41
11.56
1.1
1.5
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
212
1304
1.74
11.40
9.2
3.9
mmol/l
1.1
1.1
0.48
200
1193
(3007853) Bacteria identified in Skin by Aerobe culture
191
1143
1.78
11.30
1.7
1.6
—
—
—
0
0
(3009343) pH of Capillary blood
115
586
2.05
11.07
3.5
3.2
ph
7.5
7.4
—
6
66
(3008037) Lactate [Moles/volume] in Venous blood
56
208
2.76
10.99
3.5
2.6
mmol/l
1.5
1.5
0.07
56
201
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
36
103
3.56
10.91
1.2
1.1
u/l
58.8
70.8
0.54
16
72
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
112
570
2.05
10.82
3.4
3.1
mmol/l
1.7
1.9
0.26
81
435
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
32
85
3.83
10.79
1.2
1.5
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
24
51
4.77
10.73
1.0
1.0
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
115
594
2.02
10.67
3.5
3.2
kpa
5.0
5.2
0.97
105
556
(3005719) IgG [Mass/volume] in Serum or Plasma
141
782
1.89
10.64
3.8
2.6
g/l
9.3
10.3
2.11
130
709
(3052851) Hemolysis interference index of Serum or Plasma
76
333
2.36
10.62
4.7
3.0
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
144
807
1.88
10.52
3.2
2.6
e9/l
66.7
70.6
0.57
106
593
(1761482) Bacteria [#/volume] in Urine by Culture
63
255
2.54
10.45
5.2
4.2
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
79
357
2.29
10.30
6.2
4.6
%
1.0
0.9
0.39
74
328
(3026493) Urate [Moles/volume] in Serum or Plasma
362
2606
1.53
10.18
3.8
2.3
umol/l
6649.2
6283.0
0.04
323
2264
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
65
272
2.46
10.06
2.3
2.4
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
1342
12789
3.05
10.05
32.2
18.1
g/l
130.7
133.7
13.91
1337
12601
(3007461) Platelets [#/volume] in Blood
1341
12776
3.00
10.02
32.1
18.1
e9/l
255.0
260.0
2.15
1325
12433
(3024731) MCV [Entitic volume]
1341
12783
2.98
9.87
32.0
18.0
fl
90.9
90.8
0.51
1336
12596
(3035941) MCH [Entitic mass]
1341
12784
2.98
9.85
31.9
18.0
pg
30.2
30.2
0.17
1336
12596
(3026361) Erythrocytes [#/volume] in Blood
1341
12785
2.97
9.83
32.1
18.1
e12/l
4.4
4.5
11.63
1326
12400
(3010813) Leukocytes [#/volume] in Blood
1341
12787
2.97
9.79
32.1
18.1
e9/l
6.4
6.6
2.85
1325
12396
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
36
111
3.30
9.76
2.8
2.2
mg/l
13.6
24.5
1.42
12
31
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
58
234
2.54
9.70
3.9
3.2
u/ml
0.4
0.4
0.00
35
126
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
34
102
3.39
9.62
1.2
1.4
—
—
—
0
0
(3022313) Gas panel - Capillary blood
90
442
2.11
9.57
3.5
3.2
—
—
—
0
0
(21494434) Karyotype in Bone marrow
31
88
3.58
9.53
1.1
1.2
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
83
398
2.15
9.38
3.3
3.4
mmol/l
25.1
24.9
0.23
77
373
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
569
4536
1.43
9.37
1.9
1.9
pmol/l
98.9
96.2
0.57
274
2159
(3020779) Urea [Moles/volume] in Serum or Plasma
133
754
1.85
9.37
12.4
4.7
mmol/l
9.0
8.1
0.74
127
715
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
29
81
3.64
9.13
5.7
5.9
—
—
—
0
0
(4211845)
22
50
4.45
9.10
6.8
3.2
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
20
42
4.82
9.07
1.1
1.4
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
20
42
4.82
9.07
1.1
1.4
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
20
42
4.82
9.07
1.1
1.4
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
20
42
4.82
9.07
1.1
1.4
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
113
616
1.91
8.98
2.0
1.8
g/l
1.0
1.3
1.78
101
557
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
79
380
2.14
8.87
2.8
3.2
u/ml
163.5
3455.5
0.69
68
328
(3002032) Base excess in Venous blood by calculation
152
912
1.75
8.86
9.2
3.4
mmol/l
1.8
2.0
0.45
123
719
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
32
98
3.32
8.79
1.2
1.3
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
604
4911
1.41
8.70
2.9
2.6
ug/l
125.1
97.6
1.15
560
4527
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
124
706
1.83
8.61
1.7
1.5
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
81
402
2.08
8.40
5.0
3.3
%
47.2
48.7
0.23
81
395
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
188
1212
1.64
8.38
3.9
2.3
umol/l
7.6
7.7
0.02
168
1039
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
333
2442
1.48
8.34
2.0
1.7
mg/l
1.2
1.2
0.11
262
1844
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
94
494
1.97
8.33
9.4
8.8
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
67
311
2.21
8.24
1.8
3.3
g/l
1.3
0.2
0.61
24
124
(3018677) aPTT in Platelet poor plasma by Coagulation assay
220
1480
1.58
8.22
2.8
2.0
s
28.8
29.4
0.92
209
1429
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
231
1572
1.56
8.21
1.7
1.5
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
129
762
1.76
7.93
8.3
3.2
kpa
4.6
4.5
0.05
124
736
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
16
31
5.21
7.93
4.2
2.7
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
16
31
5.21
7.93
4.2
2.7
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
176
1131
1.64
7.93
1.6
1.6
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
149
918
1.70
7.89
9.4
3.4
kpa
5.8
5.8
0.53
143
887
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
1173
10850
1.55
7.58
6.2
5.1
mu/l
4.3
2.2
0.43
1080
9937
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
1034
9332
1.44
7.54
5.3
4.3
pmol/l
15.0
14.8
2.10
947
8501
(3033705) Calcium.ionized [Moles/volume] in Venous blood
33
114
2.94
7.46
2.2
2.1
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
14
26
5.43
7.25
1.7
1.1
—
—
—
0
0
(3026782) Osmolality of Urine
279
2030
1.47
7.16
3.6
2.4
mosm/kgh2o
543.8
540.5
0.09
253
1697
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
143
902
1.65
6.93
4.1
3.0
ng/l
86.0
72.0
1.10
123
778
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
43
179
2.45
6.81
1.4
1.2
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
42
173
2.47
6.81
1.2
1.6
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
11
17
6.51
6.78
1.1
1.2
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
19
49
3.92
6.72
1.1
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
19
49
3.92
6.72
1.1
1.0
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
18
45
4.04
6.63
6.6
3.3
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
48
213
2.30
6.61
1.3
1.4
—
—
—
0
0
(40768443) Skin Pathology biopsy report
85
468
1.87
6.60
1.3
1.2
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
45
195
2.35
6.55
1.4
1.5
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
65
328
2.03
6.50
2.0
1.8
ug/l
2.8
2.3
0.12
53
294
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
170
1137
1.56
6.47
1.7
1.6
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
45
197
2.33
6.40
1.4
1.5
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
346
2674
1.39
6.28
2.1
2.1
mg/l
3.0
2.9
0.21
296
2262
(40758358) Immune stain study
10
8
12.58
6.08
1.0
1.0
—
—
—
0
0
(3018418) pH of Serum or Plasma
419
3359
1.36
6.02
5.8
3.3
ph
7.4
7.4
2.46
40
548
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
58
290
2.04
5.97
2.2
2.1
ug/l
345.5
343.2
0.00
51
267
(3014576) Chloride [Moles/volume] in Serum or Plasma
171
1170
1.53
5.87
8.6
6.1
mmol/l
104.4
104.2
0.29
171
1143
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
15
36
4.20
5.83
6.5
1.3
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
95
563
1.74
5.82
4.8
3.1
—
—
—
0
0
(3022145) Colonoscopy Study observation
175
1209
1.51
5.74
1.3
1.3
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
418
3372
1.34
5.71
2.8
2.4
u/l
61.7
56.2
0.61
388
3085
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
20
61
3.31
5.59
1.6
1.4
u/l
14.0
3.2
—
9
27
(3006270) Folate [Moles/volume] in Blood
24
82
2.96
5.59
1.0
1.1
nmol/l
330.1
408.6
0.91
17
75
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
35
146
2.43
5.57
1.5
1.6
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
54
271
2.03
5.53
1.3
1.2
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
55
278
2.02
5.52
4.2
3.0
g/l
4.0
3.6
0.82
55
265
(3017732) Neutrophils [#/volume] in Blood
117
745
1.62
5.48
2.6
3.0
e9/l
3.9
4.0
0.09
80
578
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
77
438
1.80
5.43
1.8
1.9
u/l
38.5
39.2
0.12
71
386
(3019150) Specific gravity of Urine by Refractometry
319
2486
1.37
5.42
4.2
4.1
kg/l
1.0
1.0
1.34
46
367
(3045414) Leukocytes [Presence] in Urine
85
500
1.75
5.36
1.6
1.8
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
57
299
1.95
5.17
1.2
1.3
—
—
—
0
0
(4024509)
26
98
2.68
5.09
1.8
1.5
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
220
1627
1.42
5.08
3.4
2.7
e6/l
3.3
3.6
0.17
133
833
(3026008) Bacteria identified in Urine by Culture
438
3610
1.31
5.04
3.4
3.0
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
10
19
5.29
5.04
1.2
1.3
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
10
19
5.29
5.04
2.0
1.5
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
129
860
1.55
4.99
3.3
4.0
%
1.4
0.9
0.38
31
235
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
35
156
2.28
4.85
1.1
1.0
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
22
78
2.85
4.83
1.1
1.4
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
22
78
2.85
4.83
1.1
1.4
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
22
78
2.85
4.83
1.1
1.4
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
37
170
2.21
4.78
1.4
1.4
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
30
126
2.41
4.74
6.6
4.4
u/ml
88.9
42.2
—
9
31
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
40
191
2.13
4.70
1.8
1.7
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
136
932
1.51
4.65
9.1
6.8
%
96.9
95.6
4.22
130
894
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
12
29
4.17
4.63
1.4
1.0
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
248
1906
1.37
4.54
1.8
1.7
nmol/l
885.2
1192.6
7.78
180
1413
(3021440) Promyelocytes/100 leukocytes in Blood
122
823
1.53
4.49
3.2
4.1
%
0.5
0.1
0.96
31
215
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
1167
11025
1.39
4.49
4.9
4.4
mmol/l
5.9
5.8
0.21
1053
10017
(3009261) Glucose [Presence] in Urine by Test strip
642
5619
1.27
4.48
4.3
3.6
estimate
0.0
0.0
1.08
57
937
(36660697) Celiac disease serology panel - Serum
144
1007
1.48
4.47
1.1
1.2
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
233
1779
1.37
4.44
3.1
2.5
e6/l
1.5
1.3
0.40
144
979
(3002179) Metamyelocytes/100 leukocytes in Blood
117
786
1.53
4.40
2.5
3.9
%
0.8
0.6
0.35
24
167
(3003396) Base excess in Arterial blood by calculation
150
1063
1.46
4.35
8.6
6.4
mmol/l
1.1
1.3
0.26
116
840
(3016018) Differential panel - Cerebral spinal fluid
27
114
2.40
4.25
2.6
1.9
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
50
880
0.55
4.22
3.3
3.7
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
13
36
3.64
4.21
2.2
1.3
—
—
—
0
0
(3000991) Gas panel - Venous blood
119
811
1.51
4.19
14.5
7.0
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
634
5570
1.26
4.19
6.2
4.9
estimate
0.0
0.0
0.50
60
954
(4034850)
13
383
0.33
4.17
7.5
8.3
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
39
194
2.04
4.16
1.3
1.1
—
—
—
0
0
(4094501)
53
294
1.83
4.12
1.1
1.1
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
44
230
1.94
4.09
4.0
1.7
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
13
37
3.54
4.05
1.2
1.2
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
112
760
1.52
4.03
3.6
3.2
pmol/l
4.5
4.5
0.10
96
658
(3035350) Ketones [Presence] in Urine by Test strip
624
5503
1.25
3.89
4.0
3.6
estimate
0.0
0.0
0.00
55
942
(40761995) Spermatozoa Progressive [#/volume] in Semen
9
15
6.03
3.82
2.0
2.8
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
9
15
6.03
3.82
4.0
5.6
—
—
—
0
0
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
6
5
12.04
3.76
1.0
1.0
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
13
39
3.36
3.76
2.6
2.3
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
384
3214
1.27
3.74
3.7
3.8
mg/mmol
9.9
7.1
0.40
215
1874
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
37
189
1.98
3.70
1.2
1.2
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
10
25
4.02
3.70
1.2
1.2
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
10
25
4.02
3.70
1.2
1.2
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
143
1037
1.42
3.69
2.5
2.1
nmol/l
408.2
381.4
0.88
132
937
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
185
1402
1.37
3.69
7.9
6.1
—
—
—
0
0
(4146454)
24
103
2.35
3.68
2.5
2.7
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
29
136
2.16
3.62
1.3
1.2
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
243
1925
1.32
3.61
2.0
1.8
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
38
198
1.95
3.60
1.3
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
38
198
1.95
3.60
1.3
1.3
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
36
184
1.98
3.60
1.3
1.1
u/ml
239.5
248.8
0.05
20
100
(3030467) Casts [#/volume] in Urine by Automated count
352
2928
1.27
3.59
3.8
2.8
e6/l
0.5
0.4
0.21
279
2164
(36304419) Bacteria [Presence] in Urine
348
2895
1.27
3.55
3.8
2.8
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
14
46
3.06
3.53
3.0
2.2
u/ml
5558.3
814.2
0.57
14
46
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
38
200
1.93
3.51
1.8
3.7
%
53.3
56.9
0.97
38
200
(40768797) Stomach Pathology biopsy report
206
1601
1.34
3.49
1.3
1.2
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
12
36
3.35
3.48
5.1
1.4
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
12
36
3.35
3.48
1.2
1.2
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
19
75
2.55
3.47
1.1
1.1
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
26
119
2.21
3.46
1.4
1.4
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
37
194
1.93
3.45
1.8
3.4
e9/l
3.6
4.1
1.00
37
194
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
23
100
2.32
3.44
1.2
1.1
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
63
390
1.64
3.39
3.3
2.1
u/l
3384.7
3971.4
0.10
20
161
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
26
120
2.19
3.39
1.4
1.4
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
27
127
2.15
3.37
5.7
2.0
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
376
3174
1.25
3.37
2.3
2.0
u/l
228.9
209.0
0.07
348
2982
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
71
454
1.59
3.36
3.9
2.7
%
1.2
1.2
0.00
71
448
(40765096) Chromosome analysis panel by Banding
10
27
3.72
3.35
1.1
1.0
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
26
121
2.17
3.33
1.4
1.4
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
31
155
2.02
3.31
1.2
1.1
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
486
4230
1.23
3.28
4.3
3.8
—
—
—
0
0
(3026726) Creatinine [Moles/volume] in Specimen
6
7
8.60
3.26
1.3
1.7
umol/l
370.3
274.4
—
6
7
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
67
426
1.60
3.26
4.2
1.9
g/l
3.7
3.7
0.16
45
322
(3032057) Clostridioides difficile [Presence] in Stool
9
19
4.76
3.24
1.8
1.6
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
64
403
1.62
3.24
4.4
1.9
g/l
3.4
3.1
0.89
45
329
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
67
427
1.60
3.23
4.2
1.9
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
67
427
1.60
3.23
4.2
1.9
g/l
7.7
7.6
0.14
47
334
(3030981) Hyaline casts [#/volume] in Urine by Automated count
73
475
1.57
3.22
3.0
2.4
e6/l
0.2
0.2
0.02
73
457
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
63
398
1.61
3.15
1.9
1.9
g/l
1.6
1.5
0.21
50
349
(3024522) Salmonella sp identified in Specimen by Organism specific culture
26
124
2.12
3.15
1.4
1.4
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
30
152
2.00
3.11
4.9
2.9
%
1.2
1.6
0.23
23
117
(3021960) Folate [Moles/volume] in Serum or Plasma
306
2544
1.26
3.10
1.6
1.5
nmol/l
22.0
21.8
0.08
255
2141
(3003694) ABO and Rh group [Type] in Blood
358
3031
1.24
3.09
1.4
1.4
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
26
125
2.10
3.09
1.4
1.4
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
370
3145
1.24
3.08
4.0
2.9
e6/l
42.5
49.3
0.13
293
2364
(3002385) Erythrocyte distribution width [Ratio]
1025
9652
1.24
3.08
26.0
15.0
%
13.7
13.6
0.74
1015
9451
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
19
80
2.39
3.06
1.3
1.1
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
285
2355
1.27
3.04
1.7
1.4
g/l
2.0
2.2
1.22
168
1339
(3024869) Neuronal Ab [Presence] in Serum
7
12
5.86
3.02
1.0
1.0
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
63
403
1.59
3.01
4.0
1.9
g/l
9.7
9.9
0.09
48
350
(3009508) Creatinine [Moles/volume] in Urine
391
3353
1.23
2.99
3.1
3.0
mmol/l
6.6
7.0
1.13
323
2828
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
12
40
3.02
2.97
1.1
1.2
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
108
778
1.42
2.93
3.5
4.2
%
0.0
0.0
0.16
26
180
(3014271) Vancomycin [Susceptibility]
11
35
3.16
2.93
3.3
2.2
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
19
82
2.34
2.92
1.4
1.2
e6/l
69820.0
167759.7
0.40
11
43
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
86
596
1.47
2.87
2.7
2.3
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
35
193
1.83
2.86
1.7
1.3
—
—
—
0
0
(44790048)
21
96
2.21
2.84
1.7
1.4
—
—
—
0
0
(44806118)
21
96
2.21
2.84
1.7
1.4
—
—
—
0
0
(44790047)
21
96
2.21
2.84
1.7
1.4
—
—
—
0
0
(44790049)
21
96
2.21
2.84
1.7
1.4
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
85
591
1.47
2.79
1.2
1.2
—
—
—
0
0
(4133840)
9
23
3.93
2.77
1.1
1.1
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
25
124
2.03
2.77
1.4
1.4
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
559
4998
1.20
2.75
12.9
8.5
e9/l
0.0
0.0
4.26
454
4051
(3011397) Hemoglobin [Presence] in Urine by Test strip
320
2708
1.24
2.75
3.8
3.6
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
5
6
8.36
2.75
1.0
1.2
—
—
—
0
0
(3038026) Centromere Ab [Units/volume] in Serum
20
91
2.22
2.74
1.1
1.1
—
84.3
—
0
6
(3048929) Epstein Barr virus Ab [Presence] in Serum
55
349
1.60
2.74
1.4
1.2
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
55
349
1.60
2.74
4.4
1.8
g/l
37.8
38.3
0.17
44
309
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
1160
11123
1.27
2.71
4.7
4.3
mmol/l
4.8
4.8
0.24
1071
10264
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
296
2497
1.24
2.61
1.4
1.4
—
—
—
0
0
(3022621) pH of Urine by Test strip
102
744
1.40
2.61
4.1
3.0
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
17
74
2.31
2.58
2.5
2.1
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
39
230
1.72
2.58
2.2
1.6
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
9
25
3.62
2.57
2.2
1.4
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
114
851
1.37
2.54
4.3
2.5
g/l
65.4
66.8
1.28
102
771
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
6
11
5.47
2.54
1.3
1.2
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
43
264
1.65
2.46
4.1
1.6
e6/l
25.0
811.5
1.80
30
217
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
43
264
1.65
2.46
4.0
1.6
e6/l
2.1
17.1
2.94
30
207
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
8
21
3.82
2.46
1.5
1.0
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
8
21
3.82
2.46
1.5
1.0
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
8
21
3.82
2.46
1.4
1.2
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
8
21
3.82
2.46
1.5
1.0
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
104
770
1.38
2.45
2.0
2.3
ng/l
152.3
155.5
0.03
92
696
(3035637) Corticotropin [Mass/volume] in Plasma
27
145
1.88
2.42
1.6
1.5
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
149
1168
1.31
2.41
1.4
1.4
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
57
378
1.53
2.38
4.8
2.0
g/l
0.1
0.6
3.99
46
336
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
137
1064
1.32
2.37
9.0
6.4
kpa
5.1
5.1
0.11
130
1015
(3027801) Oxygen [Partial pressure] in Arterial blood
137
1065
1.32
2.35
9.0
6.4
kpa
13.4
12.8
0.63
131
1016
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
254
2134
1.23
2.32
3.8
2.8
mmol/l
2.5
2.5
0.21
237
1875
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
11
41
2.70
2.28
1.1
1.1
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
6
13
4.63
2.27
1.0
1.0
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
328
3764
0.83
2.25
3.1
2.7
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
7
18
3.90
2.25
4.1
1.2
ng/l
153.0
75.6
—
7
18
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
15
66
2.29
2.25
1.3
1.2
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
41
256
1.62
2.23
1.3
1.7
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
28
157
1.80
2.22
1.5
1.4
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
282
2407
1.22
2.21
3.9
4.4
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
17
81
2.11
2.13
1.1
1.1
—
2.1
—
0
7
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
13
55
2.38
2.12
1.2
1.2
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
238
2006
1.23
2.11
3.4
3.2
ng/l
967.9
270.5
0.37
171
1475
(3023199) Leukocytes [#/volume] in Pleural fluid
19
95
2.01
2.11
1.5
1.2
e6/l
9337.5
2151.1
0.43
13
64
(3049717) Cytology report of Urine Cyto stain
46
300
1.55
2.10
3.5
2.5
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
9
31
2.92
2.07
1.3
1.1
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
9
31
2.92
2.07
1.3
1.1
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
22
117
1.89
2.06
1.1
1.1
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
6
15
4.01
2.04
1.0
1.0
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
17
83
2.06
2.01
1.5
1.6
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
21
111
1.91
2.01
1.5
1.4
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
9
32
2.82
2.00
1.4
1.1
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
71
513
1.40
1.97
13.7
3.8
mmol/l
24.0
24.3
0.68
66
463
(3012516) Albumin [Mass/volume] in Urine
347
3052
1.18
1.95
2.9
3.1
mg/l
1066.3
367.3
0.77
174
1778
(3005570) Glucose [Moles/volume] in Urine
18
91
1.99
1.95
1.4
2.3
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
5
11
4.56
1.94
1.8
1.0
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
5
11
4.56
1.94
1.2
1.2
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
5
11
4.56
1.94
1.2
1.3
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
1144
11045
1.21
1.94
4.7
4.2
mmol/l
1.5
1.6
0.38
1048
10133
(3002619) Bacteria identified in Specimen by Culture
6
16
3.76
1.93
1.2
1.1
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
9
33
2.74
1.93
1.4
1.1
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
191
1591
1.23
1.91
1.4
1.3
titre
486.7
537.7
0.17
48
321
(3018095) Leukocytes [#/volume] in Urine
428
3838
1.17
1.90
4.6
3.4
e6/l
67.8
81.3
0.27
320
2581
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
48
325
1.49
1.88
4.9
1.8
g/l
0.0
0.0
0.00
43
302
(21494755) Public health laboratory ask at order entry panel
71
958
0.73
1.88
1.3
1.3
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
54
375
1.46
1.87
1.9
1.7
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
8
28
2.87
1.86
1.3
1.1
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
0
54
0.00
1.85
0.0
1.0
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
5
12
4.18
1.82
1.2
1.3
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
138
1114
1.27
1.82
4.5
4.8
ug/l
2.5
2.7
0.18
117
964
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
1169
11326
1.21
1.82
5.3
4.8
mmol/l
2.8
2.8
0.44
1072
10392
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
9
35
2.58
1.80
1.4
1.1
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
9
35
2.58
1.80
1.4
1.1
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
92
705
1.33
1.80
3.8
2.1
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
256
2209
1.20
1.79
3.2
2.3
e6/l
4.3
7.0
4.23
230
1927
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
1103
10637
1.19
1.77
4.3
3.8
mmol/l
1.3
1.3
1.15
1004
9679
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
78
586
1.35
1.74
1.6
1.5
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
8
30
2.68
1.72
11.9
3.7
%
55.7
56.4
—
8
30
(3000494) Fungus identified in Specimen by Culture
151
1241
1.24
1.72
1.6
1.4
—
—
—
0
0
(3024932) HLA-DR beta [Type]
5
13
3.86
1.71
1.0
1.2
—
—
—
0
0
(3024471) HLA-A [Type]
5
13
3.86
1.71
1.0
1.0
—
—
—
0
0
(3012565) Volume of 24 hour Urine
0
46
0.00
1.71
0.0
2.5
—
1751.0
—
0
39
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
17
89
1.92
1.70
1.3
1.5
mmol/l
11.4
11.3
—
6
19
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
48
0.00
1.70
0.0
1.1
—
158.9
—
0
48
(40768441) Liver Pathology biopsy report
16
82
1.96
1.70
1.1
1.2
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
49
342
1.45
1.68
5.4
1.8
g/l
0.0
0.0
0.50
44
317
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
19
104
1.84
1.67
1.1
1.2
—
—
—
0
0
(1002224) Polysomnography panel
28
440
0.63
1.66
1.1
1.1
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
11
49
2.25
1.63
1.8
2.2
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
5
14
3.58
1.61
1.2
6.4
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
5
14
3.58
1.61
6.4
2.6
umol/l
15.6
22.5
—
5
14
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
10
43
2.34
1.60
1.2
1.0
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
112
897
1.27
1.60
3.7
4.2
%
19.5
21.7
0.90
50
426
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
312
2766
1.17
1.58
1.3
1.3
u/ml
0.8
1.6
1.63
60
674
(3020491) Glucose [Moles/volume] in Blood
15
78
1.93
1.54
3.9
1.5
mmol/l
7.1
6.8
—
10
56
(3051387) C reactive protein [Mass/volume] in Capillary blood
36
241
1.51
1.53
3.1
3.8
mg/l
33.8
25.8
0.54
23
149
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
12
58
2.08
1.49
2.5
1.8
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
12
58
2.08
1.49
2.5
1.8
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
14
72
1.95
1.49
1.1
1.1
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
8
166
0.48
1.47
2.0
1.4
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
11
52
2.12
1.44
1.3
2.5
u/l
174.5
196.0
0.85
11
52
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
6
22
2.73
1.43
1.5
2.4
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
9
177
0.51
1.40
1.7
1.3
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
139
1162
1.22
1.38
29.2
20.0
inr
1.5
1.2
0.73
14
144
(3000093) Morphology [Interpretation] in Blood Narrative
16
89
1.81
1.37
1.1
1.1
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
1058
10235
1.15
1.34
6.5
5.4
mmol/mol
39.4
39.2
0.30
964
9440
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
40
283
1.43
1.32
2.0
1.7
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
44
317
1.40
1.32
1.1
1.2
u/ml
3.6
10.0
—
8
58
(44806420)
6
24
2.51
1.30
2.3
2.5
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
26
169
1.55
1.29
2.0
1.8
—
—
—
0
0
(4015189)
5
18
2.78
1.28
1.2
1.6
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
776
7378
1.12
1.28
3.0
3.0
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
16
92
1.75
1.25
5.0
1.8
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
92
745
1.25
1.25
1.5
1.2
u/ml
162.2
203.4
0.38
85
687
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
13
70
1.87
1.24
1.2
1.4
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
46
339
1.37
1.23
1.1
1.1
u/ml
6.7
7.4
—
7
40
(3028679) Herpes simplex virus Ab [Presence] in Serum
11
56
1.97
1.22
1.0
1.1
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
8
37
2.17
1.21
1.0
2.0
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
39
280
1.40
1.21
1.3
1.2
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
21
132
1.60
1.20
1.0
1.4
—
30.3
—
0
8
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
23
148
1.56
1.20
1.1
1.5
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
17
101
1.69
1.20
1.8
1.7
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
81
650
1.26
1.19
2.9
3.0
ug/l
0.7
0.8
0.28
62
431
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
75
597
1.27
1.18
11.0
7.6
%
1.3
1.3
0.08
75
592
(3035320) C reactive protein [Mass/volume] in Body fluid
16
94
1.71
1.17
1.5
2.1
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
241
2146
1.15
1.16
1.3
1.3
iu/ml
22.5
38.3
1.81
71
688
(3001019) Free T4 and TSH panel - Serum or Plasma
51
666
0.76
1.16
1.8
1.7
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
0
33
0.00
1.16
0.0
1.2
—
59.0
—
0
7
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
15
87
1.73
1.15
1.8
1.6
—
—
—
0
0
(3019060) Gas panel - Arterial blood
75
600
1.26
1.14
6.7
4.2
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
31
216
1.45
1.14
3.2
1.4
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
27
183
1.48
1.13
1.1
1.2
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
7
30
2.34
1.12
1.0
2.1
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
46
345
1.34
1.12
1.1
1.2
u/ml
6.5
16.2
—
6
22
(40760888) Immunoglobulin light chains.free panel - Serum
31
218
1.43
1.09
7.5
3.6
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
44
330
1.34
1.08
1.4
1.3
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
17
105
1.63
1.06
1.1
1.1
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
12
67
1.80
1.04
2.2
1.2
promille
1.0
1.3
0.37
12
52
(3017354) Segmented neutrophils/100 leukocytes in Blood
15
90
1.67
1.04
2.9
2.6
%
51.8
53.8
—
10
56
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
9
46
1.96
1.03
1.0
1.2
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
13
75
1.74
1.03
1.5
1.3
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
13
213
0.61
1.00
1.5
1.5
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
13
76
1.72
0.99
1.7
1.4
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
9
49
1.84
0.98
1.1
1.1
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
5
23
2.18
0.98
1.0
1.2
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
29
0.00
0.97
0.0
1.0
—
—
—
0
0
(44786774) Adalimumab [Mass/volume] in Serum or Plasma
0
30
0.00
0.97
0.0
2.2
—
10.4
—
0
24
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
248
2245
1.13
0.95
1.6
1.6
pmol/l
436.6
39044475.1
2.66
207
1862
(3038177) Helicobacter pylori Ab [Presence] in Serum
27
191
1.42
0.95
1.2
1.2
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
7
37
1.90
0.94
3.4
2.1
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
34
451
0.75
0.91
1.7
1.5
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
45
350
1.30
0.89
1.3
1.1
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
318
2933
1.11
0.88
3.8
3.2
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
8
43
1.87
0.87
1.1
1.3
nmol/l
127.5
142.7
—
8
43
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
47
370
1.28
0.86
1.6
1.9
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
11
64
1.72
0.86
1.3
1.1
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
13
204
0.63
0.86
1.2
1.1
u/ml
0.6
2.6
—
5
45
(3016038) Potassium [Moles/volume] in Urine
12
72
1.67
0.85
2.1
1.3
mmol/l
28.7
36.0
0.41
12
63
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
12
72
1.67
0.85
1.2
1.3
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
95
810
1.19
0.84
2.5
2.4
au/ml
13.1
23.8
—
5
44
(3006184) Hemoglobin [Mass/volume] in Capillary blood
30
222
1.36
0.84
1.6
2.0
g/l
132.5
130.1
0.20
17
157
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
43
336
1.29
0.84
1.2
1.1
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
24
173
1.39
0.79
1.7
1.4
mmol/l
64.5
62.1
0.13
19
139
(3050129) First trimester maternal screen panel - Serum or Plasma
22
304
0.72
0.78
1.4
1.4
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
106
1218
0.86
0.78
1.7
1.7
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
54
439
1.24
0.78
1.7
1.6
mg/l
3.2
4.0
0.24
42
304
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
27
360
0.74
0.77
1.4
1.3
miu/ml
345.8
252.5
—
10
177
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
50
613
0.81
0.75
2.1
1.8
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
10
161
0.62
0.75
1.0
1.0
u/ml
4.5
3.1
—
5
58
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
9
53
1.70
0.75
1.6
1.1
u/l
10.8
11.1
—
9
47
(3025018) Bordetella pertussis Ab [Titer] in Serum
13
83
1.57
0.75
1.2
1.2
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
164
1474
1.13
0.73
1.8
2.2
ug/g
152.5
118.1
0.49
124
1149
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
64
761
0.83
0.72
2.4
1.9
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
26
194
1.35
0.71
1.1
1.1
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
36
455
0.79
0.71
1.5
1.5
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
12
77
1.56
0.68
3.3
2.3
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
16
110
1.46
0.68
1.3
1.1
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
328
3071
1.09
0.68
1.7
1.6
mmol/l
1.3
1.3
0.05
302
2622
(1616796) Gas panel - Central venous blood
23
170
1.36
0.67
2.3
2.9
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
17
119
1.43
0.67
1.9
1.5
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
7
43
1.63
0.67
1.4
1.6
—
—
—
0
0
(4198724)
7
43
1.63
0.67
1.3
1.7
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
74
861
0.85
0.66
3.5
2.2
ml/min/173m2
74.8
69.3
0.59
34
342
(3037692) Legionella sp identified in Specimen by Organism specific culture
5
28
1.79
0.66
1.2
1.1
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
5
28
1.79
0.66
1.6
1.3
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
16
225
0.71
0.65
1.1
1.1
u/ml
21.6
5.5
—
5
128
(4010399)
92
803
1.16
0.65
1.3
1.4
—
—
—
0
0
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
12
79
1.52
0.62
1.2
1.1
mg/l
179.1
246.0
0.78
12
68
(3009871) Measles virus Ab [Titer] in Serum
5
30
1.67
0.61
1.4
1.7
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
8
51
1.57
0.60
11.1
3.1
—
—
—
0
0
(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma
0
20
0.00
0.60
0.0
1.6
—
564290.8
—
0
14
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
20
148
1.36
0.60
1.2
1.1
—
—
—
0
0
(4281824)
21
157
1.34
0.59
1.2
1.1
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
11
72
1.53
0.59
1.0
1.2
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
11
72
1.53
0.59
1.2
1.7
—
—
—
0
0
(3019779) Phenytoin [Moles/volume] in Serum or Plasma
0
23
0.00
0.58
0.0
2.7
—
45.5
—
0
17
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
101
1134
0.88
0.58
2.0
2.0
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
12
173
0.69
0.57
1.1
1.0
u/ml
5.8
2.0
—
6
68
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
12
81
1.49
0.57
2.0
2.4
—
—
—
0
0
(3012501) Base excess in Blood by calculation
13
183
0.71
0.55
2.2
3.1
mmol/l
1.6
2.5
—
7
130
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
53
450
1.18
0.54
1.8
1.6
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
16
116
1.38
0.54
1.1
1.1
—
—
—
0
0
(4062490)
14
99
1.42
0.54
1.4
1.5
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
117
1056
1.12
0.53
2.3
2.1
u/l
150.7
35.7
0.52
104
882
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
113
1251
0.89
0.52
2.2
2.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
22
170
1.30
0.51
1.3
1.1
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
18
135
1.34
0.51
1.1
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
22
171
1.29
0.50
1.3
1.1
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
15
110
1.37
0.49
1.1
1.5
—
—
—
0
0
(3036782) Glucose [Moles/volume] in Pleural fluid
11
76
1.45
0.48
1.4
1.2
mmol/l
6.2
6.6
0.11
11
70
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
20
255
0.78
0.47
1.2
1.1
u/ml
0.3
2.0
—
6
113
(3026470) Cobalt [Mass/volume] in Blood
7
48
1.46
0.46
1.6
2.2
ug/l
2.4
3.1
—
7
42
(3014148) Varicella zoster virus Ab [Titer] in Serum
16
120
1.34
0.46
1.1
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
42
356
1.19
0.46
1.3
1.1
—
—
—
0
0
(3014599) Egg white IgE Ab [Units/volume] in Serum
5
81
0.62
0.46
1.0
1.1
—
1.5
—
0
26
(3021901) Oxygen saturation in Capillary blood
19
147
1.30
0.45
2.3
2.3
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
14
103
1.36
0.45
1.9
2.6
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
12
86
1.40
0.44
1.4
1.2
mg/l
27.6
39.3
0.72
12
70
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
12
163
0.73
0.44
1.4
1.4
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
220
2071
1.07
0.42
1.3
1.3
u/ml
11.0
14.1
0.24
60
762
(3034426) Prothrombin time (PT)
5
32
1.56
0.42
1.0
1.3
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
17
217
0.78
0.41
1.9
1.3
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
5
33
1.52
0.41
1.6
1.3
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
42
361
1.17
0.41
1.3
1.2
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
57
503
1.14
0.40
1.3
1.4
—
—
—
0
0
(3030862) Granulocytes [#/volume] in Cerebral spinal fluid
5
35
1.43
0.39
1.0
1.2
%
—
8.0
—
0
5
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
10
71
1.41
0.39
1.0
1.2
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
28
333
0.84
0.37
4.6
3.3
mmol/l
1.2
1.3
0.84
28
328
(3020961) Endomysium IgA Ab [Titer] in Serum
52
588
0.88
0.37
1.2
1.1
—
301.4
—
0
11
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
16
125
1.28
0.37
1.1
1.5
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
10
72
1.39
0.37
1.2
1.1
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
9
70
1.29
0.36
1.0
1.3
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
244
2321
1.06
0.36
1.5
1.6
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
9
71
1.27
0.36
1.0
1.3
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
13
168
0.77
0.35
1.1
1.2
u/ml
2.7
4.7
—
6
66
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
87
951
0.91
0.35
3.6
3.1
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
13
99
1.32
0.35
1.2
1.2
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
35
403
0.86
0.33
1.4
1.6
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
15
188
0.80
0.33
1.7
1.7
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
6
46
1.31
0.33
1.0
1.2
miu/ml
880.2
1748.6
—
6
46
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
10
74
1.35
0.32
1.0
1.2
u/ml
0.0
2.6
—
5
27
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
11
143
0.77
0.32
1.1
1.1
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
17
137
1.24
0.32
1.2
1.4
pmol/l
375.1
303.9
0.31
11
109
(3008898) HLA-B27 [Presence]
39
443
0.88
0.31
1.1
1.1
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
20
165
1.22
0.31
1.8
2.4
%
17.2
16.2
0.54
13
84
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
7
52
1.35
0.31
1.3
1.7
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
38
431
0.88
0.30
1.4
1.5
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
7
56
1.25
0.29
1.0
1.2
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
58
637
0.91
0.28
1.6
1.4
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
16
194
0.82
0.27
1.7
1.9
—
—
—
0
0
(4027681)
8
65
1.23
0.27
1.4
1.2
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
12
150
0.80
0.27
1.2
1.3
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
8
66
1.21
0.26
1.6
1.7
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
74
683
1.09
0.26
1.1
1.0
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
13
160
0.81
0.26
1.1
1.1
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
9
73
1.23
0.25
1.7
1.4
g/l
0.9
1.0
—
9
73
(3034274) Bile acid [Moles/volume] in Serum --fasting
17
142
1.20
0.24
2.6
2.1
umol/l
4.3
8.6
1.00
11
94
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
10
78
1.28
0.24
1.3
1.2
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
21
180
1.17
0.23
1.4
1.7
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
5
39
1.28
0.23
1.4
2.3
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
28
248
1.13
0.21
1.8
1.7
e6/l
26932.2
8548.2
0.54
23
176
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
5
42
1.19
0.21
1.2
1.1
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3010015) Selenium [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
2.1
—
1.3
—
0
10
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3028029) Mesothelial cells/100 leukocytes in Pleural fluid
0
10
0.00
0.21
0.0
1.7
—
1.0
—
0
5
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
10.5
—
—
—
0
0
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.2
—
8.5
—
0
11
(3016273) Islet cell 512 Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.0
—
5.5
—
0
7
(3016031) Almond IgE Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.1
—
1.2
—
0
7
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
0
13
0.00
0.21
0.0
2.6
—
0.6
—
0
13
(3036312) Salmon IgE Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.0
—
0.4
—
0
6
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
13
0.00
0.21
0.0
1.2
—
1.5
—
0
13
(3044889) 12 lead EKG panel
796
7861
1.03
0.20
3.7
3.4
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
13
108
1.21
0.20
1.1
1.6
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
40
437
0.91
0.19
1.4
1.6
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
26
291
0.89
0.19
4.8
3.5
mmol/l
3.9
3.8
0.37
26
271
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
35
318
1.10
0.19
1.5
1.8
iu/l
7.4
5.1
0.23
13
103
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
17
196
0.87
0.18
3.2
2.1
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
18
156
1.16
0.18
1.2
1.4
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
40
435
0.92
0.18
1.4
1.6
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
302
2945
1.03
0.18
3.8
4.0
estimate
0.0
0.0
1.08
54
942
(3023419) Bacteria identified in Sputum by Culture
13
110
1.18
0.17
2.7
2.6
—
—
—
0
0
(3010838) Calcium [Moles/time] in 24 hour Urine
5
69
0.72
0.17
1.2
1.5
—
9.8
—
0
6
(3000570) Elastase.pancreatic [Mass/mass] in Stool
35
321
1.09
0.16
1.5
1.4
ug/g
291.7
291.4
0.00
23
189
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
26
287
0.90
0.16
1.8
1.4
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
26
287
0.90
0.16
1.3
2.0
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
78
821
0.95
0.16
1.1
1.2
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
40
431
0.93
0.15
1.4
1.6
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
79
751
1.06
0.15
2.6
2.2
ug/l
3.4
5.4
1.98
58
651
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
89
932
0.95
0.15
1.8
1.6
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
10
84
1.19
0.14
1.2
1.1
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
14
122
1.15
0.13
1.1
1.1
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
31
335
0.92
0.13
1.4
1.6
—
—
—
0
0
(4268621)
9
110
0.82
0.13
1.8
2.3
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
26
281
0.92
0.11
2.2
2.0
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
5
44
1.14
0.10
1.2
1.6
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
5
44
1.14
0.10
1.0
1.1
—
—
—
0
0
(3017704) Immunofixation for Urine
5
47
1.06
0.09
2.4
1.2
—
—
—
0
0
(44813793)
10
87
1.15
0.09
1.2
1.1
—
—
—
0
0
(3010421) pH of Blood
24
223
1.08
0.09
2.1
2.9
ph
7.4
7.4
0.86
12
181
(3043238) Trisomy 21 risk [Likelihood] in Fetus
19
206
0.92
0.08
1.6
1.4
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
19
206
0.92
0.08
5.3
3.1
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
22
204
1.08
0.08
2.5
2.2
ug/min
40.2
110.8
1.16
13
128
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
5
61
0.82
0.08
1.0
1.8
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
7
66
1.06
0.08
1.4
1.5
—
1.4
—
0
6
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
7
68
1.03
0.08
11.0
11.8
mmol/l
0.7
0.6
—
7
62
(3045683) HLA typing for celiac disease panel - Blood or Tissue
8
76
1.05
0.07
1.0
1.0
—
—
—
0
0
(4306422)
16
147
1.09
0.07
1.3
1.1
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
95
974
0.97
0.07
1.6
1.6
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
10
89
1.12
0.07
2.1
1.3
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
15
138
1.09
0.06
1.1
1.2
nmol/l
—
—
—
0
0
(40761535) Cells panel - Urine sediment
86
879
0.98
0.05
3.9
3.4
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
117
1150
1.02
0.05
1.6
1.6
%
1.4
1.4
0.20
105
1024
(3011648) Oxygen content in Venous blood
10
91
1.10
0.04
4.4
4.0
%
11.6
11.5
—
10
91
(3004716) Salmonella sp identified in Stool by Organism specific culture
68
666
1.02
0.04
1.4
1.3
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
19
199
0.95
0.03
1.5
1.4
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
19
199
0.95
0.03
1.5
1.4
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
89
900
0.99
0.02
1.1
1.2
iu/ml
107.9
147.1
0.70
31
342
(3000492) Spirometry study
104
1030
1.01
0.02
1.7
1.4
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
11
117
0.94
0.01
3.0
3.4
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
27
263
1.03
0.01
1.6
1.5
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
11
106
1.04
0.00
1.1
1.8
%
90.0
89.9
0.05
11
106
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
11
110
1.00
0.00
1.2
1.9
pg
33.6
31.9
0.86
11
110
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
24
243
0.99
0.00
1.5
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
24
243
0.99
0.00
1.5
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
24
243
0.99
0.00
1.5
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
24
243
0.99
0.00
1.5
1.4
—
—
—
0
0
(3020891) Body temperature
37
368
1.01
0.00
5.1
3.9
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
10
97
1.03
0.00
1.3
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
10
97
1.03
0.00
1.3
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
10
97
1.03
0.00
1.3
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
10
98
1.02
0.00
1.3
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
10
98
1.02
0.00
1.3
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
10
98
1.02
0.00
1.3
1.2
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
18
175
1.03
0.00
1.5
1.5
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
21
205
1.02
0.00
1.5
1.1
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
16
162
0.99
0.00
1.1
1.3
nmol/l
0.5
0.6
0.97
16
152
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
36
365
0.99
0.00
1.4
1.5
iu/ml
0.1
0.1
—
8
78
(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis
0
8
0.00
0.00
0.0
4.0
—
47.6
—
0
8
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011048) Pyruvate [Moles/volume] in Blood
0
8
0.00
0.00
0.0
1.1
—
98.8
—
0
8
(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose
0
8
0.00
0.00
0.0
1.1
—
7.7
—
0
8
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3022475) Manganese [Moles/volume] in Blood
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004959) Base excess in Arterial cord blood by calculation
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
0
6
0.00
0.00
0.0
3.3
—
—
—
0
0
(3013466) aPTT in Blood by Coagulation assay
0
6
0.00
0.00
0.0
1.0
—
34.7
—
0
6
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
2.5
—
0
6
(3016750) Collection duration of Urine
5
49
1.02
0.00
3.2
1.8
min
532.6
481.0
—
5
38
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
5
51
0.98
0.00
1.4
1.4
—
—
—
0
0
(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
0
9
0.00
0.00
0.0
1.0
—
37.7
—
0
9
(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
0
9
0.00
0.00
0.0
1.0
—
8.3
—
0
9
(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
7
69
1.01
0.00
3.3
2.1
ml
815.0
583.4
—
7
48
(3006598) pH of Arterial cord blood
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042517) Benzodiazepines panel - Urine
0
5
0.00
0.00
0.0
3.2
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3013336) Amino acids [Identifier] in Serum or Plasma
0
7
0.00
0.00
0.0
2.9
—
—
—
0
0
(3001729) Color of Synovial fluid
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
5
53
0.94
0.00
1.8
1.5
—
—
—
0
0
(3032700) Glomerular basement membrane Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
5
53
0.94
0.00
1.2
2.2
—
—
—
0
0
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
0
9
0.00
0.00
0.0
1.0
—
21.6
—
0
9
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
9
92
0.98
0.00
1.0
1.2
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
6
62
0.97
0.00
1.0
1.1
—
—
—
0
0
(3008860) Bordetella pertussis IgM Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3006442) Creatine [Moles/volume] in Serum or Plasma
6
59
1.02
0.00
1.3
1.3
—
68.1
—
0
7
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: Z21_PERSONAL_HISTORY_MALIG_NEOPLASM – Personal history of malignant neoplasm
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).